Literature DB >> 24998016

Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy.

Dietmar Winkler1, Edda Pjrek2, Rupert Lanzenberger2, Pia Baldinger2, Daniel Eitel2, Siegfried Kasper2, Richard Frey2.   

Abstract

Depressive disorder is frequently accompanied by changes in psychomotor activity and disturbances of the sleep-wake cycle. The chronobiological effects of electroconvulsive therapy (ECT) in patients with treatment-resistant depression (TRD) are largely unknown. The objective of the current study was to measure the influence of ECT on patients' activity and sleep. 15 patients with unipolar TRD were treated with ECT. Activity levels were measured with wrist actigraphy before and after ECT. Remission rate (score on the 17-item Hamilton Depression Rating Scale lower than 8 points) was 40.0%. Remitters had increases of 56.0% on light activity, 49.8% on total activity, and 70.2% on circadian amplitude, while there was no significant change of these variables in subjects who did not experience remission. The circadian acrophase and actigraphic sleep-parameters were not significantly affected by treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actigraphic measurements; Activity; Chronobiology; ECT; Sleep–wake cycle; Treatment-resistant depression

Mesh:

Year:  2014        PMID: 24998016     DOI: 10.1016/j.jpsychires.2014.06.006

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

1.  A rest-activity biomarker to predict response to SSRIs in major depressive disorder.

Authors:  W Vaughn McCall
Journal:  J Psychiatr Res       Date:  2015-03-06       Impact factor: 4.791

2.  Electroconvulsive Seizure Alters the Expression and Daily Oscillation of Circadian Genes in the Rat Frontal Cortex.

Authors:  Se Hyun Kim; Hong Geun Park; Seong Hoon Jeong; Ung Gu Kang; Yong Min Ahn; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2018-06-28       Impact factor: 2.505

Review 3.  Current Advances in Wearable Devices and Their Sensors in Patients With Depression.

Authors:  Seunggyu Lee; Hyewon Kim; Mi Jin Park; Hong Jin Jeon
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

4.  A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression.

Authors:  J T O'Brien; P Gallagher; D Stow; N Hammerla; T Ploetz; M Firbank; C Ladha; K Ladha; D Jackson; R McNaney; I N Ferrier; P Olivier
Journal:  Psychol Med       Date:  2016-09-26       Impact factor: 7.723

Review 5.  Phenothiazines Modified with the Pyridine Ring as Promising Anticancer Agents.

Authors:  Beata Morak-Młodawska; Małgorzata Jeleń; Krystian Pluta
Journal:  Life (Basel)       Date:  2021-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.